SCHEMBL14979285

SCHEMBL14979285

C=C1OC(Br)c2ccc([N+](=O)[O-])cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
PTPRC P08575 3/20 0.42
S100A4 P26447 2/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 1/20 0.41
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
CES1 P23141 1/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
HSP90AA1 P07900 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30095404 0.83 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL4702204 0.83 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL2532509 0.67 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL6673213 0.67 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL12181050 0.66 PTPRC (0.67) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL13508699 0.66 ALDH1A1 (0.74) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL7741732 0.64 PTPRC (0.63) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL19207373 0.64 TSHR (0.56) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL19243529 0.64 TSHR (0.56) ALDH1A1PTPRCS100A4MAPTKDM4E
SCHEMBL25407711 0.64 ALDH1A1 (0.55) ALDH1A1PTPRCS100A4MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072825-A1 PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-05-23 WO disclosed